Anna Elgart Valitsky

Title: The Innovations of Anna Elgart Valitsky

Introduction

Anna Elgart Valitsky is a notable inventor based in Kfar-Saba, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of psychiatric diseases. With a total of two patents to her name, her work focuses on innovative formulations that enhance the efficacy of psychiatric medications.

Latest Patents

Valitsky's latest patents include a long-acting injectable formulation comprising risperidone and biodegradable polymers. This invention is directed towards methods of treating psychiatric diseases and disorders, allowing for administration at a frequency of no more than once every 28 days. The formulation includes risperidone at a concentration of 250-400 mg/mL, with an injection volume of 1 mL or less. Another significant patent is for olanzapine compositions and methods of use, which provides pharmaceutical compositions for subcutaneous administration. This patent includes olanzapine, an organic solvent, and both triblock and diblock copolymers, along with methods for treating psychiatric diseases using these compositions.

Career Highlights

Anna Valitsky is currently associated with Medincell S.A., a company known for its innovative drug delivery systems. Her work at Medincell has allowed her to focus on developing advanced pharmaceutical solutions that address critical health issues.

Collaborations

Valitsky collaborates with talented professionals in her field, including Mélodie Carluer and Maria Ferrand. These collaborations enhance her research and contribute to the development of effective treatments.

Conclusion

Anna Elgart Valitsky's contributions to the field of pharmaceuticals, particularly in psychiatric treatment, highlight her innovative spirit and dedication to improving patient care. Her patents reflect a commitment to advancing medical science through effective drug formulations.